Same Indication

Metformin vs Upadacitinib

Metformin vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Metformin and Upadacitinib.

Mechanism of Action

Metformin: Activates AMP-activated protein kinase, decreasing hepatic glucose production.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Metformin — 4-9 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Metformin — C4H11N5; Upadacitinib — C17H19F3N6O.

Molecular Weight: Metformin — 129.1640 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Metformin — Small molecule; Upadacitinib — Small molecule.